Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Eye, Ear, Nose and Throat›Trichiasis

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Trichiasis

Eye, Ear, Nose and Throat · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

A disease of the eye in which the eyelashes abnormally turn inwards toward the eyeball producing constant irritation caused by motion of the lids.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (677 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A disease of the eye in which the eyelashes abnormally turn inwards toward the eyeball producing constant irritation caused by motion of the lids.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Trichiases.

Where it fits in the MeSH classification

Broader topics
Eyelid Diseases

Research landscape

PubMed indexes 324 records tagged with the MeSH heading “Trichiasis” (counts retrieved 2026-11-04). 123 of them (38.0%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 173 records.

Reviews account for 17 records (5.2%) and meta-analyses for 2. Randomized controlled trials number 23 (7.1%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 27 records; 2000-2009: 1 records; 2010-2019: 173 records; 2020 onward: 123 records27through 199912000-20091732010-20191232020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199927
2000-20091
2010-2019173
2020 onward123
Share of records by publication typeReviews: 5.2 percent; Meta-analyses: 0.6 percent; Randomized controlled trials: 7.1 percentReviews5.2% (17)Meta-analyses0.6% (2)Randomized controlled trials7.1% (23)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 324 PubMed records
TypeRecordsShare
Reviews175.2%
Meta-analyses20.6%
Randomized controlled trials237.1%

Method: PubMed query "Trichiasis"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in eye, ear, nose and throat

Eye, hearing, nose and throat studies rely on specialist tests (visual acuity, eye pressure, audiograms, scopes) and on patient-reported symptoms, which vary between people and with age. Some conditions improve without treatment, so comparison groups matter. Nothing on this page is advice about diagnosis or treatment; sudden loss of sight or hearing needs urgent care from a qualified clinician. Check how the outcome was tested, the age of the people studied and how long they were followed.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
The simplified trachoma grading system, amended
Solomon AW, Kello AB, Bangert M, West SK, Taylor HR, Tekeraoi R, et al.
2020Research article
Design not recorded in structured metadata
73cc by
PMID 33177759 · DOI · PMC7652564
Trachoma and Relative Poverty: A Case-Control Study
Habtamu E, Wondie T, Aweke S, Tadesse Z, Zerihun M, Zewdie Z, et al.
2015Research article
Design not recorded in structured metadata
62cc by
PMID 26600211 · DOI · PMC4657919
Trachomatous trichiasis and its management in endemic countries
Rajak SN, Collin JR, Burton MJ
2012Review article
Design not recorded in structured metadata
57cc by
PMID 22285842 · DOI · PMC3316859
Trachoma prevalence surveys in 15 indigenous and non-indigenous evaluation units in Brazil, 2018-2023
Szwarcwald CL, Lopes MFC, de Souza Junior PRB, Gómez DVF, Luna EJA, de Almeida WDS, et al.
2026Research article
Design not recorded in structured metadata
0cc by
PMID 40590257 · DOI · PMC13017592

The simplified trachoma grading system, amended [1]

Research article Solomon AW, Kello AB, Bangert M, West SK, Taylor HR, Tekeraoi R, et al. · · 2020 · cited 73 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
A simplified grading system for trachoma was published by the World Health Organization (WHO) in 1987.
Closing excerpt
This paper presents the amended system, updates its presentation, offers notes on its use and identifies areas of ongoing debate.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (137 words)

A simplified grading system for trachoma was published by the World Health Organization (WHO) in 1987. Intended for use by non-specialist personnel working at community level, the system includes five signs, each of which can be present or absent in any eye: (i) trachomatous trichiasis; (ii) corneal opacity; (iii) trachomatous inflammation-follicular; (iv) trachomatous inflammation-intense; and (v) trachomatous scarring. Though neither perfectly sensitive nor perfectly specific for trachoma, these signs have been essential tools for identifying populations that need interventions to eliminate trachoma as a public health problem. In 2018, at WHO's 4th global scientific meeting on trachoma, the definition of one of the signs, trachomatous trichiasis, was amended to exclude trichiasis that affects only the lower eyelid. This paper presents the amended system, updates its presentation, offers notes on its use and identifies areas of ongoing debate.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 33177759 · DOI · PMC7652564

Trachoma and Relative Poverty: A Case-Control Study [2]

Research article Habtamu E, Wondie T, Aweke S, Tadesse Z, Zerihun M, Zewdie Z, et al. · · 2015 · cited 62 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundTrachoma is widely considered a disease of poverty.
Closing excerpt
Trachoma is a good proxy of inequality within communities and it could be used to target and evaluate interventions for health and poverty alleviation.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (217 words)

BackgroundTrachoma is widely considered a disease of poverty. Although there are many epidemiological studies linking trachoma to factors normally associated with poverty, formal quantitative data linking trachoma to household economic poverty within endemic communities is very limited.Methodology/principal findingsTwo hundred people with trachomatous trichiasis were recruited through community-based screening in Amhara Region, Ethiopia. These were individually matched by age and gender to 200 controls without trichiasis, selected randomly from the same sub-village as the case. Household economic poverty was measured through (a) A broad set of asset-based wealth indicators and relative household economic poverty determined by principal component analysis (PCA, (b) Self-rated wealth, and (c) Peer-rated wealth. Activity participation data were collected using a modified 'Stylised Activity List' developed for the World Bank's Living Standards Measurement Survey. Trichiasis cases were more likely to belong to poorer households by all measures: asset-based analysis (OR = 2.79; 95%CI: 2.06-3.78; pConclusions/significanceThis study demonstrated a strong association between trachomatous trichiasis and relative poverty, suggesting a bidirectional causative relationship possibly may exist between poverty and trachoma. Implementation of the full SAFE strategy in the context of general improvements might lead to a virtuous cycle of improving health and wealth. Trachoma is a good proxy of inequality within communities and it could be used to target and evaluate interventions for health and poverty alleviation.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26600211 · DOI · PMC4657919

Trachomatous trichiasis and its management in endemic countries [3]

Review article Rajak SN, Collin JR, Burton MJ · · 2012 · cited 57 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Trichiasis is the sight-threatening consequence of conjunctival scarring in trachoma, the most common infectious cause of blindness worldwide.
Closing excerpt
We examine the principles of clinical management, treatment options, and the challenging issues of providing the quantity and quality of surgery that is needed in resource-poor settings.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (126 words)

Trichiasis is the sight-threatening consequence of conjunctival scarring in trachoma, the most common infectious cause of blindness worldwide. Trachomatous trichiasis is the result of multiple infections from childhood with Chlamydia trachomatis, which causes recurrent chronic inflammation in the tarsal conjunctiva. This produces conjunctival scarring, entropion, trichiasis, and ultimately blinding corneal opacification. The disease causes painful, usually irreversible sight loss. Over eight million people have trachomatous trichiasis, mostly those living in poor rural communities in 57 endemic countries. The global cost is estimated at US$ 5.3 billion. The WHO recommends surgery as part of the SAFE strategy for controlling the disease.We examine the principles of clinical management, treatment options, and the challenging issues of providing the quantity and quality of surgery that is needed in resource-poor settings.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 22285842 · DOI · PMC3316859

Trachoma prevalence surveys in 15 indigenous and non-indigenous evaluation units in Brazil, 2018-2023 [4]

Research article Szwarcwald CL, Lopes MFC, de Souza Junior PRB, Gómez DVF, Luna EJA, de Almeida WDS, et al. · · 2026

Abstract reading summary — source excerpts
Opening excerpt
BackgroundTo provide the groundwork for a future declaration of elimination of trachoma as a public health problem in Brazil, we conducted house-to-house surveys following WHO methodological guidance.
Closing excerpt
The findings on sanitary conditions mandate public policies to overcome socioenvironmental inequalities.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (197 words)

BackgroundTo provide the groundwork for a future declaration of elimination of trachoma as a public health problem in Brazil, we conducted house-to-house surveys following WHO methodological guidance.MethodsAn observational cross-sectional study was conducted in 10 non-indigenous and five indigenous evaluation units (EUs) from 2018 to 2023; data on six EUs are reported here for the first time. Two-stage cluster sampling was used: 30 clusters per EU, and 30 households per cluster. We estimated the prevalence of trachomatous inflammation-follicular (TF) in 1-9-y-olds and trachomatous trichiasis (TT) unknown to the health system in those aged ≥15 y. Data on sanitary conditions were collected in household interviews.ResultsIn all EUs, TF prevalence was below the elimination threshold (5%). TT prevalence was lower than the 0.2% threshold in 14 EUs. In 'Noroeste Cearense' mesoregion, TT prevalence was 0.22% (95% CI 0.06 to 0.44%), but statistical analysis showed a 58% likelihood of TT elimination in this EU. In three indigenous EUs, >10% of households had no sanitary facilities and high percentages of open defecation.ConclusionsIt is highly likely that trachoma has been eliminated as a public health problem in all the EUs surveyed. The findings on sanitary conditions mandate public policies to overcome socioenvironmental inequalities.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40590257 · DOI · PMC13017592

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Trachoma [5]
    Solomon AW, Burton MJ, Gower EW, Harding-Esch EM, Oldenburg CE, Taylor HR, et al. · Nat Rev Dis Primers · 2022 · cited 129 times (Europe PMC)
  • Research article Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease [6]
    Ramadhani AM, Derrick T, Holland MJ, Burton MJ · PLoS Negl Trop Dis · 2016 · cited 52 times (Europe PMC)
  • Research article The costs of monitoring trachoma elimination: Impact, surveillance, and trachomatous trichiasis (TT)-only surveys [7]
    Stelmach RD, Flueckiger RM, Shutt J, Davide-Smith M, Solomon AW, Rotondo L, et al. · PLoS Negl Trop Dis · 2019 · cited 14 times (Europe PMC)
  • Research article Systematic review of the incidence of post-operative trichiasis in Africa [8]
    Mwangi G, Courtright P, Solomon AW · BMC Ophthalmol · 2020 · cited 12 times (Europe PMC)
  • Research article Community-level trachoma ecological associations and the use of geospatial analysis methods: A systematic review [9]
    Burgert-Brucker CR, Adams MW, Mingkwan P, Flueckiger R, Ngondi JM, Solomon AW, et al. · PLoS Negl Trop Dis · 2022 · cited 11 times (Europe PMC)
  • Research article Trichiasis: characteristics and management options [10]
    Kirkwood BJ, Kirkwood RA · Insight · 2011 · cited 5 times (Europe PMC)

References

  1. Solomon AW, Kello AB, Bangert M, West SK, Taylor HR, Tekeraoi R, et al.. The simplified trachoma grading system, amended. . 2020. PMID 33177759 · DOI · PMC7652564
  2. Habtamu E, Wondie T, Aweke S, Tadesse Z, Zerihun M, Zewdie Z, et al.. Trachoma and Relative Poverty: A Case-Control Study. . 2015. PMID 26600211 · DOI · PMC4657919
  3. Rajak SN, Collin JR, Burton MJ. Trachomatous trichiasis and its management in endemic countries. . 2012. PMID 22285842 · DOI · PMC3316859
  4. Szwarcwald CL, Lopes MFC, de Souza Junior PRB, Gómez DVF, Luna EJA, de Almeida WDS, et al.. Trachoma prevalence surveys in 15 indigenous and non-indigenous evaluation units in Brazil, 2018-2023. . 2026. PMID 40590257 · DOI · PMC13017592
  5. Solomon AW, Burton MJ, Gower EW, Harding-Esch EM, Oldenburg CE, Taylor HR, et al.. Trachoma. Nat Rev Dis Primers. 2022. PMID 35618795 · DOI
  6. Ramadhani AM, Derrick T, Holland MJ, Burton MJ. Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease. PLoS Negl Trop Dis. 2016. PMID 27483002 · DOI · PMC4970760
  7. Stelmach RD, Flueckiger RM, Shutt J, Davide-Smith M, Solomon AW, Rotondo L, et al.. The costs of monitoring trachoma elimination: Impact, surveillance, and trachomatous trichiasis (TT)-only surveys. PLoS Negl Trop Dis. 2019. PMID 31487281 · DOI · PMC6728015
  8. Mwangi G, Courtright P, Solomon AW. Systematic review of the incidence of post-operative trichiasis in Africa. BMC Ophthalmol. 2020. PMID 33203380 · DOI · PMC7670604
  9. Burgert-Brucker CR, Adams MW, Mingkwan P, Flueckiger R, Ngondi JM, Solomon AW, et al.. Community-level trachoma ecological associations and the use of geospatial analysis methods: A systematic review. PLoS Negl Trop Dis. 2022. PMID 35395003 · DOI · PMC9020723
  10. Kirkwood BJ, Kirkwood RA. Trichiasis: characteristics and management options. Insight. 2011. PMID 21717925

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • AniseikoniaEye, Ear, Nose and Throat
  • AphakiaEye, Ear, Nose and Throat
  • AsthenopiaEye, Ear, Nose and Throat
  • AstigmatismEye, Ear, Nose and Throat
  • BlepharoptosisEye, Ear, Nose and Throat
  • CataractEye, Ear, Nose and Throat

All 51 articles in Eye, Ear, Nose and Throat →

At a glance

324
PubMed records on this heading
38%
published since 2020
17
review articles
23
randomized trials
10
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • AniseikoniaEye, Ear, Nose and Throat
  • AphakiaEye, Ear, Nose and Throat
  • AsthenopiaEye, Ear, Nose and Throat
  • AstigmatismEye, Ear, Nose and Throat
  • BlepharoptosisEye, Ear, Nose and Throat

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support